Total Payments
$1.5M
2024 Payments
$126,993
Companies
18
Transactions
1,496
Medicare Patients
453
Medicare Billing
$51,510
Payment Breakdown by Category
Other$1.1M (69.8%)
Consulting$290,364 (18.7%)
Travel$147,691 (9.5%)
Food & Beverage$25,538 (1.6%)
Gifts$2,733 (0.2%)
Research$521.91 (0.0%)
Education$429.49 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1.0M | 341 | 67.7% |
| Consulting Fee | $290,364 | 75 | 18.7% |
| Travel and Lodging | $147,691 | 587 | 9.5% |
| Honoraria | $33,057 | 9 | 2.1% |
| Food and Beverage | $25,538 | 468 | 1.6% |
| Gift | $2,733 | 2 | 0.2% |
| Unspecified | $521.91 | 6 | 0.0% |
| Education | $429.49 | 8 | 0.0% |
Payments by Type
General
$1.5M
1,490 transactions
Research
$521.91
6 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $646,753 | 673 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $238,784 | 235 | $0 (2024) |
| Genentech USA, Inc. | $212,027 | 147 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $178,090 | 166 | $0 (2024) |
| EMD Serono, Inc. | $113,381 | 113 | $0 (2024) |
| Amgen Inc. | $37,587 | 30 | $0 (2024) |
| Horizon Therapeutics plc | $36,892 | 36 | $0 (2023) |
| Celgene Corporation | $33,642 | 35 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $17,694 | 15 | $0 (2017) |
| Biogen, Inc. | $11,080 | 18 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $126,993 | 94 | EMD Serono, Inc. ($46,467) |
| 2023 | $144,970 | 111 | Alexion Pharmaceuticals, Inc. ($60,350) |
| 2022 | $83,427 | 94 | Genentech USA, Inc. ($28,996) |
| 2021 | $87,792 | 69 | GENZYME CORPORATION ($32,154) |
| 2020 | $47,111 | 40 | GENZYME CORPORATION ($16,654) |
| 2019 | $385,111 | 398 | GENZYME CORPORATION ($147,708) |
| 2018 | $320,430 | 293 | GENZYME CORPORATION ($222,530) |
| 2017 | $352,902 | 397 | GENZYME CORPORATION ($175,881) |
All Payment Transactions
1,496 individual payment records from CMS Open Payments — Page 1 of 60
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | EMD Serono, Inc. | Mavenclad (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,463.00 | General |
| Category: Neurology | ||||||
| 12/05/2024 | EMD Serono, Inc. | Mavenclad (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,463.00 | General |
| Category: Neurology | ||||||
| 12/02/2024 | EMD Serono, Inc. | Mavenclad (Drug) | Travel and Lodging | Cash or cash equivalent | $852.96 | General |
| Category: Neurology | ||||||
| 12/02/2024 | EMD Serono, Inc. | Mavenclad (Drug) | Travel and Lodging | Cash or cash equivalent | $684.00 | General |
| Category: Neurology | ||||||
| 12/02/2024 | EMD Serono, Inc. | Mavenclad (Drug) | Travel and Lodging | Cash or cash equivalent | $166.37 | General |
| Category: Neurology | ||||||
| 11/29/2024 | Genentech USA, Inc. | Ocrevus (Biological) | Travel and Lodging | Cash or cash equivalent | $142.04 | General |
| Category: Immunology | ||||||
| 11/21/2024 | Genentech USA, Inc. | Ocrevus (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,520.00 | General |
| Category: Immunology | ||||||
| 11/20/2024 | Amgen Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,850.00 | General |
| 11/20/2024 | Amgen Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,750.00 | General |
| 11/13/2024 | Amgen Inc. | — | Travel and Lodging | Cash or cash equivalent | $219.09 | General |
| 11/12/2024 | Amgen Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,300.00 | General |
| 11/12/2024 | Amgen Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $550.00 | General |
| 11/08/2024 | EMD Serono, Inc. | Mavenclad (Drug) | Travel and Lodging | Cash or cash equivalent | $174.87 | General |
| Category: Neurology | ||||||
| 11/06/2024 | Amgen Inc. | UPLIZNA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,300.00 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/04/2024 | EMD Serono, Inc. | Mavenclad (Drug) | Travel and Lodging | Cash or cash equivalent | $978.37 | General |
| Category: Neurology | ||||||
| 11/04/2024 | EMD Serono, Inc. | Mavenclad (Drug) | Travel and Lodging | Cash or cash equivalent | $65.00 | General |
| Category: Neurology | ||||||
| 11/02/2024 | Amgen Inc. | UPLIZNA (Biological) | Travel and Lodging | In-kind items and services | $394.95 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/02/2024 | Amgen Inc. | UPLIZNA (Biological) | Travel and Lodging | In-kind items and services | $303.97 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/02/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $49.99 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/02/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $49.99 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/02/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/02/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/01/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/29/2024 | Genentech USA, Inc. | Ocrevus (Biological) | Consulting Fee | Cash or cash equivalent | $1,035.00 | General |
| Category: Immunology | ||||||
| 10/28/2024 | EMD Serono, Inc. | Mavenclad (Drug) | Travel and Lodging | Cash or cash equivalent | $1,272.93 | General |
| Category: Neurology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| MS700568-0078 | EMD Serono, Inc. | $521.91 | 6 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 143 | 161 | $62,382 | $13,998 |
| 2022 | 3 | 98 | 114 | $26,554 | $10,856 |
| 2021 | 3 | 117 | 140 | $42,256 | $15,320 |
| 2020 | 4 | 95 | 108 | $32,139 | $11,337 |
Total Patients
453
Total Services
523
Medicare Billing
$51,510
Procedure Codes
13
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 71 | 86 | $25,026 | $5,530 | 22.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 43 | 46 | $19,550 | $4,808 | 24.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 29 | 29 | $17,806 | $3,659 | 20.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 53 | 66 | $12,874 | $4,967 | 38.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 28 | 31 | $8,326 | $3,430 | 41.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 17 | 17 | $5,354 | $2,458 | 45.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 56 | 71 | $16,543 | $5,979 | 36.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 34 | 42 | $13,104 | $5,347 | 40.8% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 27 | 27 | $12,609 | $3,994 | 31.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 37 | 48 | $11,184 | $3,952 | 35.3% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 31 | 33 | $10,296 | $3,650 | 35.4% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 12 | 12 | $5,289 | $1,971 | 37.3% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 15 | 15 | $5,370 | $1,764 | 32.9% |
About Dr. Jill Conway, MD
Dr. Jill Conway, MD is a Neurology healthcare provider based in Charlotte, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1205991502.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jill Conway, MD has received a total of $1.5M in payments from pharmaceutical and medical device companies, with $126,993 received in 2024. These payments were reported across 1,496 transactions from 18 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($1.0M).
As a Medicare-enrolled provider, Conway has provided services to 453 Medicare beneficiaries, totaling 523 services with total Medicare billing of $51,510. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Charlotte, NC
- Active Since 12/27/2006
- Last Updated 03/31/2023
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1205991502
Products in Payments
- AUBAGIO (Drug) $353,136
- LEMTRADA (Drug) $247,601
- GILENYA (Drug) $120,407
- OCREVUS (Biological) $112,180
- Ocrevus (Biological) $53,814
- Mavenclad (Drug) $49,472
- Non-Covered Product (Drug) $45,269
- MAYZENT (Drug) $37,558
- UPLIZNA (Drug) $36,892
- Mavenclad (Biological) $25,533
- SOLIRIS (Drug) $25,223
- UPLIZNA (Biological) $23,494
- SOLIRIS (Biological) $22,311
- ZEPOSIA (Drug) $19,654
- Soliris (Drug) $19,650
- COPAXONE (Drug) $17,613
- ULTOMIRIS (Biological) $16,742
- Ozanimod (Drug) $16,458
- DISEASE STATE (Drug) $10,749
- TYSABRI (Biological) $10,624
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Charlotte
Sanjay Iyer, Md, MD
Neurology — Payments: $620,868
Neurology $620,868
Dr. Megan Donnelly, D.o, D.O
Neurology — Payments: $471,292
Neurology $471,292
Danielle Englert Doggett, Md, MD
Neurology — Payments: $224,230
Neurology $224,230
Ardith Courtney, Do, DO
Neurology — Payments: $215,565
Neurology $215,565
Mohammad Bolouri, Md, MD
Neurology — Payments: $184,450
Neurology $184,450
Joseph Chipman, Md, MD
Neurology — Payments: $120,418
Neurology $120,418